CLIENT TESTIMONIALS
We highly appreciate the assistance offered by DAS Capital. The team conducted comprehensive market analysis throughout the project and was competent, maintaining a greatly effective service all the time. DAS Capital also provided valuable advice in our corporate development strategy. Hope to success with DAS Capital again in the future!
-Nutshell Therapeutics, CEO, Dr. Shen Qiancheng
We are thankful for the professional work provided by DAS Capital and also for the support from famous funds. During roadshow preparation and key term negotiation , their expertise and efficiency have made the dealing smoothly. We look forward to devoting on innovations in China’s Pharmaceutical industry together with DAS Capital again.
-Sciwind, Founder & CEO, Dr. Pan Hai
This was the second round financing cooperation between HeartCare and DAS Capital and the team provided excellent services as ever. Thanks for the professional services offered for the key consulting role on financing pacing, investors matching, key terms negotiation and market analyzing. We are delighted to continue work and accomplish with DAS Capital on the billions of dollars neuro-intervention devices market!
-HeartCare, Founder & CEO, Mr. Wang Guohui
DAS Capital’s expertise and diligence has greatly boosted the dealing. During the project, they offered great assistance on building product competing strategies, determining technology advantages and structuring business rationale. DAS Capital meanwhile provided tactical and professional suggestions for company’s business development and financial planning. As for business plan , roadshows and follow-up, terms negotiation and final closing, they always maintained their high-quality work effectively and thoughtfully.
-Insight Lifetech, Co-founder & Chairman, Dr. Song Liang
We appreciate the diligent work from DAS Capital in this financing round, helping to quickly solidify terms and whole process control. DAS Capital had a deep insight for the market and their comprehensive market analysis has greatly increase the dealing and due-diligence process efficiency. Their team was highly responsible and thoughtful and the service they provided were professional and effectively. DAS Capital is a trusted partner.
-PUSHKANG, Founder, Dr. Yu Bo
SBD-Strategic Business Development
The “DAS approach” includes studying the client’s vision, strategy, and business model in the first place.Developing frameworks to evaluate and pursue opportunities, and identify short, middle, and long-term priorities.Therefore, we can identify, propose and complete transactions in line with company strategy, and achieve managed-risks investments.
“DAS approach” activities include:
- Business intelligence: monitor trends in the industry, competitors’ tactics, and strategies.
- Exploring business and investment opportunities: identify opportunities in various stages of the industry value chain and mode of participation such as investment/acquisitions, joint ventures/alliances, and greenfield. Perform strategic analysis and financial evaluation of projects. Build relationships/liaisons with potential sellers, partners, and government authorities.
- Materializing opportunities: perform due diligence and advise on post-merger integration.
And we help them to expand options of potential M&A, joint venture& alliance candidates and improve the odds of finding good opportunities that are off the radar of any other acquirer.
SBD-Strategic Business Development
Private Placement
SBD-Strategic Business Development
The “DAS approach” includes studying the client’s vision, strategy, and business model in the first place.Developing frameworks to evaluate and pursue opportunities, and identify short, middle, and long-term priorities.Therefore, we can identify, propose and complete transactions in line with company strategy, and achieve managed-risks investments.
“DAS approach” activities include:
- Business intelligence: monitor trends in the industry, competitors’ tactics, and strategies.
- Exploring business and investment opportunities: identify opportunities in various stages of the industry value chain and mode of participation such as investment/acquisitions, joint ventures/alliances, and greenfield. Perform strategic analysis and financial evaluation of projects. Build relationships/liaisons with potential sellers, partners, and government authorities.
- Materializing opportunities: perform due diligence and advise on post-merger integration.
And we help them to expand options of potential M&A, joint venture& alliance candidates and improve the odds of finding good opportunities that are off the radar of any other acquirer.
SBD-Strategic Business Development
The “DAS approach” includes studying the client’s vision, strategy, and business model in the first place.Developing frameworks to evaluate and pursue opportunities, and identify short, middle, and long-term priorities.Therefore, we can identify, propose and complete transactions in line with company strategy, and achieve managed-risks investments.
“DAS approach” activities include:
- Business intelligence: monitor trends in the industry, competitors’ tactics, and strategies.
- Exploring business and investment opportunities: identify opportunities in various stages of the industry value chain and mode of participation such as investment/acquisitions, joint ventures/alliances, and greenfield. Perform strategic analysis and financial evaluation of projects. Build relationships/liaisons with potential sellers, partners, and government authorities.
- Materializing opportunities: perform due diligence and advise on post-merger integration.
And we help them to expand options of potential M&A, joint venture& alliance candidates and improve the odds of finding good opportunities that are off the radar of any other acquirer.
Mergers and Acquisitions Advisory
Private Placement
We are created for start-ups and growth ventures, DAS Capital as the right partner covering the specific areas tailored to each case for a successful journey.
We make sure capital raising activities align with the company’s long-term strategy. We will build a custom team of capital-raising experts partnered with our industry specialists to leverage sector-specific insights that will help us to better position your company for maximum reception by investors.
The private placement process involves, among other things, tracking the constantly changing investment appetites of the decision-makers at those firms that invest in Life Sciences.
As DAS Capital often acts as a strategic advisor to most of the companies for which it undertakes a private placement, its ability to articulate the scientific and clinical achievements as well as the business strategy of its client is greatly enhanced, and for the same reason, its credibility with investing institutions is increased. In the meantime, our ECM team is continuously tracking more than 4000 institutional investors to update investors' profiles, and gauge changing appetites and market dynamics.
Therefore, we could precisely identify potential investors and eventually close the deal in a timely fashion.
Mergers and Acquisitions Advisory
No two deals are the same in the sell-side advisory field, which means we understand the uniqueness of your opportunity and goal. We start every relationship by listening and asking questions to better understand your transactional goals and then collaborating with you to create a customized plan to optimize your outcome.
Our team will execute your transaction with the utmost skill, tenacity, and tact resulting in faster closing times, a higher probability of close and market-leading multiples.
For buy-side advisory, our industry-focused M&A advisors will combine deep sector expertise with superior transaction execution skills, and a vast network of strategic and financial relationships to help achieve your goals. Negotiating in the middle markets is not for the faint of heart. We manage a process that will help you identify, approach, and negotiate with potential middle market targets that meet your criteria and achieve a successful outcome.
RECENT TRANSACTIONS
Life Science
- Medical devices Biotechnology
- Medical equipment Novel drugs
- Implantable devices Generic drugs
- Scientific research tools e-Healthcare
- Point-of-care test Digital Therapy
- Reagent & consumables CRO
- Lab automation systems CDMO
Material Science
- Membrane materials Electronic materials
- Fibrous composites materials Rare earth materials
- New energy materials
- Semiconductor materials
- Biomaterials Display materials
TRACK RECORDS
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29